Mark S. Ordan Sells 33,000 Shares of Pediatrix Medical Group, Inc. (NYSE:MD) Stock

Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) Director Mark S. Ordan sold 33,000 shares of the firm’s stock in a transaction dated Thursday, May 25th. The stock was sold at an average price of $13.26, for a total transaction of $437,580.00. Following the completion of the sale, the director now owns 147,923 shares of the company’s stock, valued at approximately $1,961,458.98. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Pediatrix Medical Group Stock Up 0.7 %

NYSE MD traded up $0.09 during trading on Friday, reaching $13.36. 310,743 shares of the company’s stock traded hands, compared to its average volume of 688,327. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.44 and a quick ratio of 1.44. The firm has a market cap of $1.12 billion, a price-to-earnings ratio of 10.88, a price-to-earnings-growth ratio of 2.34 and a beta of 1.74. The company’s 50 day simple moving average is $14.24 and its two-hundred day simple moving average is $14.98. Pediatrix Medical Group, Inc. has a 12-month low of $12.84 and a 12-month high of $23.95.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in MD. Pacer Advisors Inc. purchased a new position in Pediatrix Medical Group during the 1st quarter valued at about $12,439,000. Norges Bank purchased a new position in shares of Pediatrix Medical Group in the 4th quarter worth approximately $11,064,000. Lazard Asset Management LLC grew its position in shares of Pediatrix Medical Group by 24.3% in the 1st quarter. Lazard Asset Management LLC now owns 3,263,699 shares of the company’s stock worth $76,631,000 after buying an additional 637,798 shares during the last quarter. ArrowMark Colorado Holdings LLC grew its position in shares of Pediatrix Medical Group by 11.2% in the 4th quarter. ArrowMark Colorado Holdings LLC now owns 4,048,957 shares of the company’s stock worth $60,168,000 after buying an additional 407,239 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in shares of Pediatrix Medical Group by 8.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,861,170 shares of the company’s stock worth $57,569,000 after buying an additional 306,469 shares during the last quarter. Hedge funds and other institutional investors own 95.99% of the company’s stock.

Analysts Set New Price Targets

MD has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Pediatrix Medical Group from $15.50 to $14.00 in a report on Wednesday, May 3rd. Truist Financial reduced their price target on shares of Pediatrix Medical Group from $17.00 to $15.00 in a research note on Tuesday, May 9th. Mizuho reduced their price target on shares of Pediatrix Medical Group from $17.00 to $15.00 in a research note on Wednesday, May 3rd. StockNews.com initiated coverage on shares of Pediatrix Medical Group in a research note on Thursday, May 18th. They issued a “hold” rating on the stock. Finally, Credit Suisse Group reduced their price target on shares of Pediatrix Medical Group from $27.00 to $23.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 22nd. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Pediatrix Medical Group presently has an average rating of “Hold” and an average target price of $17.67.

Pediatrix Medical Group Company Profile

(Get Rating)

Pediatrix Medical Group, Inc engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.